Company
Trained Therapeutix Discovery
- Biotech
- Location:
- Oss, Netherlands
Description
Trained Therapeutix Discovery develops nanobiologic therapeutics that regulate trained immunity for applications in cancer and organ inflammation, delivering modular nanomedicine products to biomedical and clinical researchers and clinicians.
Trained Therapeutix Discovery is located in the Netherlands ecosystem.
Related
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
CyclomicsCyclomics develops molecular diagnostics and DNA sequencing products including the CySeq consensus sequencing and liquid biopsy platform…
ORCA TherapeuticsORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead candidate ORCA-010 for treatment‑naive…
MILabsMILabs builds modular molecular and anatomical imaging systems and unified software enabling researchers to visualize tracer behavior,…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…
OrganOxOrganOx builds and supplies the OrganOx metra liver perfusion device platform for normothermic machine perfusion, used by clinicians to…
Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
MESIMESI builds integrated diagnostic hardware and software (MESI mTABLET and modular measurement devices) for clinicians to perform vital…